The Research & Development team at Autobahn Therapeutics is dedicated to advancing innovative therapies for CNS disorders. They focus on drug discovery, translational medicine, and clinical development to harness the regenerative potential of the human body and improve patient outcomes.
Bruce Cree
Scientific Advisor
Chan Beals
SVP Translational Medicine
Edmund Harrigan
Scientific Advisor
Gudarz Davar
Evp, Head Of Research And Deve...
Jason Harris
Vp, Head Of Preclinical Resear...
Jeffrey Vivian
Executive Director - Translati...
Jill Baccei
Director, Medicinal Chemistry
Maurizio Fava
Scientific Advisor
Robert Conley
Scientific Advisor
Tom Scanlan
Scientific Advisor
View all